Patent · US Active

Modified immune-modulating particles

US11020424B2 · kind B2 · utility

0Cited by

4References

9Claims

0Family size

Assignee

onCour Pharma, Inc. · US

Inventors

Daniel R. Getts · Evanston, US
Rachael Terry · Sydney, AU
Nicholas King · San Diego, US

Key dates

Filing date	Oct 3, 2018
Grant date	Jun 1, 2021
Priority date	—
Expiry date	Oct 3, 2038

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY10T428/2982
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The presently claimed invention relates to methods of reducing the duration or severity of an inflammatory immune response. In embodiments, the method comprises administering poly (lactic acid) (PLA) particles, poly (glycolic acid) (PGA) particles, poly (lactic-co-glycolic acid) (PLGA) particles, or combinations thereof; wherein said particles are modified to contain one or more carboxyl groups on the particle's surface. In embodiments, the particles do not comprise therapeutically active ingredients.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.